CVE-2024-7016: Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in S
CVE-2024-7016 is a medium-severity flaw (CVSS 4.8) affecting smart doctor. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Smarttek Informatics Smart Doctor's allows Stored XSS required admin privileges. This issue affects Smart Doctor: through 21.11.2024. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 4.8 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | High |
| User interaction | Required |
| EPSS exploit chance | 0.4% (top 67%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2024-11-21 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2024-7016?
smart doctor: upgrade to newer than 2024-11-21. Exact commands for each OS are on this page.
Is CVE-2024-7016 being exploited?
CVE-2024-7016 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2024-7016 affect?
CVE-2024-7016 affects smart doctor. Severity is medium (CVSS 4.8). Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Smarttek Informatics Smart Doctor's allows Stored XSS required admin privileges. This issue affects Smart Doctor: through 21.11.20
How urgent is CVE-2024-7016?
Priority 25/100. No elevated risk signals yet.